ACXP logo

Acurx Pharmaceuticals (ACXP) Enterprise Value

Enterprise Value

$2.17 M
-$2.57 M-54.26%

Sat, 08 Mar 2025 00:51:24 GMT


Summary


Performance

ACXP Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherACXPvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

ACXP Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-54.3%-24.5%-24.5%
1 m1 month-71.4%-40.6%-40.6%
3 m3 months-70.0%-38.9%-38.9%
6 m6 months-91.6%-75.3%-76.3%
ytdytd-72.0%-41.3%-41.3%
1 y1 year-94.0%-81.8%-84.5%
5 y5 years---

ACXP Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-72.4%$2.17 Mat low
3 m3-month$11 M-79.9%$2.17 Mat low
6 m6-month$31 M-93.1%$2.17 Mat low
1 y1-year$40 M-94.5%$2.17 Mat low
3 y3-year$76 M-97.1%$2.17 Mat low
5 y5-year$76 M-97.1%$2.17 Mat low
alltimeall time$76 M-97.1%$2.17 Mat low

Acurx Pharmaceuticals Enterprise Value History

DateValue
2025
$2.17 M(-72.0%)
2024
$7.75 M(-84.2%)
DateValue
2023
$48.95 M(+31.7%)
2022
$37.17 M(+19.2%)
2021
$31.18 M

FAQ

  • What is Acurx Pharmaceuticals enterprise value?
  • What is the all time high enterprise value for Acurx Pharmaceuticals?
  • What is ACXP enterprise value year-to-date change?
  • What is Acurx Pharmaceuticals enterprise value year-on-year change?

What is Acurx Pharmaceuticals enterprise value?

The current enterprise value of ACXP is $2.17 M

What is the all time high enterprise value for Acurx Pharmaceuticals?

Acurx Pharmaceuticals all-time high enterprise value is $75.56 M

What is ACXP enterprise value year-to-date change?

Acurx Pharmaceuticals enterprise value has changed by -$5.58 M (-72.00%) since the beginning of the year

What is Acurx Pharmaceuticals enterprise value year-on-year change?

Over the past year, ACXP enterprise value has changed by -$34.05 M (-94.01%)